DOI: 10.1200/po.23.00063 ISSN:

Fam-Trastuzumab Deruxtecan in HER2/Neu-Expressing Serous Endometrial Cancer

Peter G. Rose, Johanna A. Kelley, Myra Feldman, Kevin Krivanek
  • Cancer Research
  • Oncology

Trastuzumab deruxtecan treatment of 3 patients with HER2/neu-expressing serous endometrial cancer resulted in objective response

More from our Archive